4//SEC Filing
Yoon Hankil 4
Accession 0002041300-25-000003
CIK 0001894525other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 6:39 PM ET
Size
5.9 KB
Accession
0002041300-25-000003
Insider Transaction Report
Form 4
Yoon Hankil
Director
Transactions
- Award
Stock Option (right to buy)
2025-11-11+10,000→ 10,000 totalExercise: $2.67Exp: 2035-11-11→ Common Stock, par value $0.01 per share (10,000 underlying)
Footnotes (1)
- [F1]The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan.
Documents
Issuer
Apimeds Pharmaceuticals US, Inc.
CIK 0001894525
Entity typeother
Related Parties
1- filerCIK 0002041300
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 6:39 PM ET
- Size
- 5.9 KB